Literature DB >> 9270587

Evidence for association of HLA-A2 allele with onset age of Alzheimer's disease.

H Payami1, G D Schellenberg, S Zareparsi, J Kaye, G J Sexton, M A Head, S S Matsuyama, L F Jarvik, B Miller, D Q McManus, T D Bird, R Katzman, L Heston, D Norman, G W Small.   

Abstract

Our earlier studies had suggested a possible association between the HLA-A2 allele and Alzheimer's disease (AD). In the present study we tested the hypothesis that A2 is associated with earlier AD onset. We performed two independent studies: a collaborative study with 111 patients and a confirmatory study with 96 patients. We found similar patterns of reduced age at onset as a function of A2 in both data sets. Overall, A2 was associated with a significant 3-year shift to earlier onset. The effects of A2 and epsilon 4 on age at onset appeared additive. Our results suggest A2, or a closely linked gene, modulates onset age of AD. Association with A2 would suggest an immune/inflammatory response mechanism for AD.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9270587     DOI: 10.1212/wnl.49.2.512

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  9 in total

Review 1.  Structural and functional distinctiveness of HLA-A2 allelic variants.

Authors:  Kenneth Yuanxiang Chen; Jingxian Liu; Ee Chee Ren
Journal:  Immunol Res       Date:  2012-09       Impact factor: 2.829

Review 2.  Advances and challenges in the prevention and treatment of Alzheimer's disease.

Authors:  R Diaz Brinton; R S Yamazaki
Journal:  Pharm Res       Date:  1998-03       Impact factor: 4.200

3.  An Efficient Nonlinear Regression Approach for Genome-wide Detection of Marginal and Interacting Genetic Variations.

Authors:  Seunghak Lee; Aurélie Lozano; Prabhanjan Kambadur; Eric P Xing
Journal:  J Comput Biol       Date:  2016-05       Impact factor: 1.479

Review 4.  Causes of Alzheimer's disease.

Authors:  D G Munoz; H Feldman
Journal:  CMAJ       Date:  2000-01-11       Impact factor: 8.262

5.  Association study of Notch 4 polymorphisms with Alzheimer's disease.

Authors:  J-C Lambert; D Mann; J Harris; L Araria-Goumidi; M-C Chartier-Harlin; D Cottel; T Iwatsubo; P Amouyel; C Lendon
Journal:  J Neurol Neurosurg Psychiatry       Date:  2004-03       Impact factor: 10.154

6.  Immune surveillance in the injured nervous system: T-lymphocytes invade the axotomized mouse facial motor nucleus and aggregate around sites of neuronal degeneration.

Authors:  G Raivich; L L Jones; C U Kloss; A Werner; H Neumann; G W Kreutzberg
Journal:  J Neurosci       Date:  1998-08-01       Impact factor: 6.167

7.  A myristoylated calcium-binding protein that preferentially interacts with the Alzheimer's disease presenilin 2 protein.

Authors:  S M Stabler; L L Ostrowski; S M Janicki; M J Monteiro
Journal:  J Cell Biol       Date:  1999-06-14       Impact factor: 10.539

8.  Fine-mapping of the human leukocyte antigen locus as a risk factor for Alzheimer disease: A case-control study.

Authors:  Natasha Z R Steele; Jessie S Carr; Luke W Bonham; Ethan G Geier; Vincent Damotte; Zachary A Miller; Rahul S Desikan; Kevin L Boehme; Shubhabrata Mukherjee; Paul K Crane; John S K Kauwe; Joel H Kramer; Bruce L Miller; Giovanni Coppola; Jill A Hollenbach; Yadong Huang; Jennifer S Yokoyama
Journal:  PLoS Med       Date:  2017-03-28       Impact factor: 11.069

Review 9.  Similarity and Differences in Inflammation-Related Characteristics of the Peripheral Immune System of Patients with Parkinson's and Alzheimer's Diseases.

Authors:  Anna A Boyko; Natalya I Troyanova; Elena I Kovalenko; Alexander M Sapozhnikov
Journal:  Int J Mol Sci       Date:  2017-12-06       Impact factor: 5.923

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.